These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

481 related items for PubMed ID: 27813491

  • 1. Hyperin protects against LPS-induced acute kidney injury by inhibiting TLR4 and NLRP3 signaling pathways.
    Chunzhi G, Zunfeng L, Chengwei Q, Xiangmei B, Jingui Y.
    Oncotarget; 2016 Dec 13; 7(50):82602-82608. PubMed ID: 27813491
    [Abstract] [Full Text] [Related]

  • 2. Hyperin inhibits nuclear factor kappa B and activates nuclear factor E2-related factor-2 signaling pathways in cisplatin-induced acute kidney injury in mice.
    Chao CS, Tsai CS, Chang YP, Chen JM, Chin HK, Yang SC.
    Int Immunopharmacol; 2016 Nov 13; 40():517-523. PubMed ID: 27764742
    [Abstract] [Full Text] [Related]

  • 3. Tenuigenin exhibits protective effects against LPS-induced acute kidney injury via inhibiting TLR4/NF-κB signaling pathway.
    Fu H, Hu Z, Di X, Zhang Q, Zhou R, Du H.
    Eur J Pharmacol; 2016 Nov 15; 791():229-234. PubMed ID: 27546562
    [Abstract] [Full Text] [Related]

  • 4. Zingerone ameliorates lipopolysaccharide-induced acute kidney injury by inhibiting Toll-like receptor 4 signaling pathway.
    Song J, Fan HJ, Li H, Ding H, Lv Q, Hou SK.
    Eur J Pharmacol; 2016 Feb 05; 772():108-14. PubMed ID: 26698392
    [Abstract] [Full Text] [Related]

  • 5. Nerolidol Protects Against LPS-induced Acute Kidney Injury via Inhibiting TLR4/NF-κB Signaling.
    Zhang L, Sun D, Bao Y, Shi Y, Cui Y, Guo M.
    Phytother Res; 2017 Mar 05; 31(3):459-465. PubMed ID: 28093813
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Protopine Protects Mice against LPS-Induced Acute Kidney Injury by Inhibiting Apoptosis and Inflammation via the TLR4 Signaling Pathway.
    Zhang B, Zeng M, Li M, Kan Y, Li B, Xu R, Wu Y, Wang S, Zheng X, Feng W.
    Molecules; 2019 Dec 19; 25(1):. PubMed ID: 31861525
    [Abstract] [Full Text] [Related]

  • 11. Alirocumab boosts antioxidant status and halts inflammation in rat model of sepsis-induced nephrotoxicity via modulation of Nrf2/HO-1, PCSK9/HMGB1/NF-ᴋB/NLRP3 and Fractalkine/CX3CR1 hubs.
    Hassan NF, El-Ansary MR, Selim HMRM, Ousman MS, Khattab MS, El-Ansary MRM, Gad ES, Moursi SMM, Gohar A, Gowifel AMH.
    Biomed Pharmacother; 2024 Aug 19; 177():116929. PubMed ID: 38889644
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. 5-O-methyldihydroquercetin and cilicicone B isolated from Spina Gleditsiae ameliorate lipopolysaccharide-induced acute kidney injury in mice by inhibiting inflammation and oxidative stress via the TLR4/MyD88/TRIF/NLRP3 signaling pathway.
    Zeng M, Qi M, Wang Y, Xu R, Wu Y, Li M, Zheng X, Feng W.
    Int Immunopharmacol; 2020 Mar 19; 80():106194. PubMed ID: 31986326
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Genipin alleviates LPS-induced acute lung injury by inhibiting NF-κB and NLRP3 signaling pathways.
    Zhang A, Wang S, Zhang J, Wu H.
    Int Immunopharmacol; 2016 Sep 19; 38():115-9. PubMed ID: 27262946
    [Abstract] [Full Text] [Related]

  • 17. Involvement of S100A8/A9-TLR4-NLRP3 Inflammasome Pathway in Contrast-Induced Acute Kidney Injury.
    Tan X, Zheng X, Huang Z, Lin J, Xie C, Lin Y.
    Cell Physiol Biochem; 2017 Sep 19; 43(1):209-222. PubMed ID: 28854431
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. S-nitrosoglutathione protects lipopolysaccharide-induced acute kidney injury by inhibiting toll-like receptor 4-nuclear factor-κB signal pathway.
    Fan H, Zhao Y, Zhu JH.
    J Pharm Pharmacol; 2019 Aug 19; 71(8):1255-1261. PubMed ID: 31115903
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.